A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
NCT07216027
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Eczema, Atopic
Interventions
DRUG:
PF-08049820
DRUG:
Placebo
Sponsor
Pfizer